{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:57:02Z","timestamp":1768867022796,"version":"3.49.0"},"reference-count":8,"publisher":"Georg Thieme Verlag KG","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1055\/a-1158-9214","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T01:39:40Z","timestamp":1605231580000},"page":"776-778","source":"Crossref","is-referenced-by-count":2,"title":["Exceptional Response of Nelson\u2019s Syndrome to Pasireotide LAR in the Long-Term Follow-up of 9 Years"],"prefix":"10.1055","volume":"129","author":[{"given":"Sandra M.","family":"Fill","sequence":"additional","affiliation":[{"name":"Urological Clinic und Poliklinik f\u00fcr Urologie, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6832-1992","authenticated-orcid":false,"given":"Kathrin H.","family":"Popp","sequence":"additional","affiliation":[{"name":"Medicover Neuroendocrinology Prof. Stalla and Colleagues, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnter K.","family":"Stalla","sequence":"additional","affiliation":[{"name":"Medicover Neuroendocrinology Prof. Stalla and Colleagues, Munich"},{"name":"Medizinische Klinik und Poliklinik IV, Klinikum der Universit\u00e4t, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia P.","family":"Athanasoulia-Kaspar","sequence":"additional","affiliation":[{"name":"Medicover Neuroendocrinology Prof. Stalla and Colleagues, Munich"},{"name":"Urological Clinic und Poliklinik f\u00fcr Urologie, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM195807242590403","article-title":"ACTH-producing tumor of the pituitary gland","volume":"259","author":"D H Nelson","year":"1958","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/2014.10.FOCUS14681","article-title":"Nelson\u2019s syndrome: A review of the clinical manifestations, pathophysiology, and treatment strategies","volume":"38","author":"J Patel","year":"2015","journal-title":"Neurosurg Focus"},{"key":"ref3","first-page":"623092","article-title":"Temozolomide-induced shrinkage of invasive pituitary adenoma in patient with Nelson\u2019s Syndrome: A case report and review of the literature","volume":"2015","author":"M Kurowska","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1358\/dot.2013.49.2.1915142","article-title":"Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors","volume":"49","author":"R A Feelders","year":"2013","journal-title":"Drugs Today (Barc)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/jc.2008-2101","article-title":"Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas","volume":"94","author":"C de Bruin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2014.10.FOCUS14700","article-title":"Cushing\u2019s disease: Current medical therapies and molecular insights guiding future therapies","volume":"38","author":"D Lau","year":"2015","journal-title":"Neurosurg Focus"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2013-1497","article-title":"Sustained improvements in plasma ACTH and clinical status in a patient with Nelson\u2019s syndrome treated with pasireotide LAR, a multireceptor somatostatin analog","volume":"98","author":"L Katznelson","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11102-017-0853-3","article-title":"A prospective longitudinal study of Pasireotide in Nelson\u2019s syndrome","volume":"21","author":"E Daniel","year":"2018","journal-title":"Pituitary"}],"container-title":["Experimental and Clinical Endocrinology & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1158-9214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T01:11:29Z","timestamp":1633396289000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1158-9214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":8,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,4]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1158-9214","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}